NIMBLE Diagnostics Raises $12M Series A to Revolutionize Non-Invasive Stent Monitoring

NIMBLE Diagnostics, a pioneering force in stent care and non-invasive diagnostics, has recently raised $12,000,000 in its latest funding round. This significant capital injection is set to accelerate the development of their groundbreaking microwave-based technology designed to monitor the functional integrity of stents. Stents, one of the most implanted devices in the world, play a crucial role in restoring proper blood flow and preventing heart attacks. However, over time, these devices can become blocked or damaged—a situation that affects nearly a third of patients. Traditionally, any signs of potential failure are only detected when the stent is already 90% occluded. At this advanced stage, invasive checks via angiography become necessary, involving complicated procedures that require catheter insertion, anesthesia, excessive X-ray exposure, and prolonged hospital recovery periods. Not only does this pose significant risks to patients, but it also places a heavy financial burden on healthcare systems. Recognizing these challenges, NIMBLE Diagnostics is developing a novel solution that harnesses microwave-based technology to non-invasively read the electromagnetic signature of a stent and detect early signs of in-stent restenosis, thrombosis, or stent fractures. By enabling earlier intervention, this pioneering system aims to reduce the incidence of life-threatening complications such as strokes, heart attacks, and sudden death. The newly raised funds will directly support the refinement of this technology and accelerate its journey through rigorous clinical trials. With this transformative approach, NIMBLE Diagnostics is paving the way toward more proactive and less invasive cardiac care, ultimately ensuring better patient outcomes and long-term cardiovascular health.